{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:42:16Z","timestamp":1793983336401,"version":"4.8.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.taap.2022.116250","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T11:06:32Z","timestamp":1663671992000},"page":"116250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data"],"prefix":"10.1016","volume":"454","author":[{"given":"Lin","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K.","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilatha","family":"Sakamuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.116250_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1289\/ehp.1408642","article-title":"Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential","volume":"123","author":"Attene-Ramos","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2022.116250_bb0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ijcard.2016.10.102","article-title":"Role of ranolazine in cardiovascular disease and diabetes: exploring beyond angina","volume":"227","author":"Banerjee","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.taap.2022.116250_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bjh.13108","article-title":"Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial","volume":"168","author":"Brummendorf","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.taap.2022.116250_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/19440049.2017.1400186","article-title":"Assessment of elimination profile of albendazole residues in fish","volume":"35","author":"Busatto","year":"2018","journal-title":"Food Addit. Contam. Part A Chem. Anal. Control Expo Risk Assess"},{"key":"10.1016\/j.taap.2022.116250_bb0040","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","article-title":"Risk factors for idiosyncratic drug-induced liver injury","volume":"138","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2022.116250_bb0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1021\/tx800063r","article-title":"Shape signatures: new descriptors for predicting cardiotoxicity in silico","volume":"21","author":"Chekmarev","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"Chen","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2022.116250_bb0055","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acs.est.1c02656","article-title":"Revealing adverse outcome pathways from public high-throughput screening data to evaluate new toxicants by a knowledge-based deep neural network approach","volume":"55","author":"Ciallella","year":"2021","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.taap.2022.116250_bb0060","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1021\/acs.est.2c01040","article-title":"Predicting prenatal developmental toxicity based on the combination of chemical structures and biological data","volume":"56","author":"Ciallella","year":"2022","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.taap.2022.116250_bb0065","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1126\/science.1154619","article-title":"Toxicology. Transforming environmental health protection","volume":"319","author":"Collins","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.taap.2022.116250_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/mutage\/ger053","article-title":"Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs","volume":"27","author":"Creton","year":"2012","journal-title":"Mutagenesis"},{"key":"10.1016\/j.taap.2022.116250_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17425255.2017.1337746","article-title":"Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab","volume":"13","author":"Dokmanovic","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vascn.2013.12.003","article-title":"Progress in computational toxicology","volume":"69","author":"Ekins","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.taap.2022.116250_bb0085","author":"EPA"},{"key":"10.1016\/j.taap.2022.116250_bb0090","series-title":"Erythromycin","author":"Farzam","year":"2022"},{"key":"10.1016\/j.taap.2022.116250_bb0015","author":"FDA"},{"key":"10.1016\/j.taap.2022.116250_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pharmthera.2013.03.005","article-title":"Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity","volume":"138","author":"Ferri","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2022.116250_bb0100","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/mds.10342","article-title":"Entacapone-induced hepatotoxicity and hepatic dysfunction","volume":"17","author":"Fisher","year":"2002","journal-title":"Mov. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2022.116250_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(97)82328-8","article-title":"Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation","volume":"26","author":"Fromenty","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2022.116250_bb0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2010.920","article-title":"Risk of acute myocardial infarction, stroke, heart failure, and death in elderly medicare patients treated with rosiglitazone or pioglitazone","volume":"304","author":"Graham","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2022.116250_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tiv.2017.01.004","article-title":"Alternative approaches for identifying acute systemic toxicity: moving from research to regulatory testing","volume":"41","author":"Hamm","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.taap.2022.116250_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","article-title":"Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria","volume":"34","author":"Han","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.taap.2022.116250_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081897","article-title":"An in silico model for predicting drug-induced hepatotoxicity","volume":"20","author":"He","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2022.116250_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/157340311799960636","article-title":"Cardiotoxicity of molecularly targeted agents","volume":"7","author":"Hedhli","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.taap.2022.116250_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-00663-0_1","article-title":"Drug-induced liver injury","author":"Holt","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.taap.2022.116250_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-0716-2213-1_13","article-title":"A quantitative high-throughput screening data analysis pipeline for activity profiling","volume":"2474","author":"Huang","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.taap.2022.116250_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2022.116250_bb0150","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1038\/ncomms10425","article-title":"Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization","volume":"7","author":"Huang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2022.116250_bb0155","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1038\/s41598-018-22046-w","article-title":"Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles","volume":"8","author":"Huang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2022.116250_bb0160","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.drudis.2019.09.019","article-title":"The NCATS pharmaceutical collection: a 10-year update","volume":"24","author":"Huang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2022.116250_bb0165","series-title":"Clinical and Research Information on Drug-Induced Liver Injury","author":"in LiverTox","year":"2012"},{"key":"10.1016\/j.taap.2022.116250_bb0170","author":"Institute, N. N. C"},{"key":"10.1016\/j.taap.2022.116250_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2011.602688","article-title":"Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity","volume":"44","author":"Jaeschke","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.taap.2022.116250_bb0180","doi-asserted-by":"crossref","first-page":"129193","DOI":"10.1016\/j.jhazmat.2022.129193","article-title":"Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay","volume":"436","author":"Jia","year":"2022","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.taap.2022.116250_bb0185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/FJC.0000000000000891","article-title":"The Glitazars paradox: cardiotoxicity of the metabolically beneficial dual PPARalpha and PPARgamma activation","volume":"76","author":"Kalliora","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.taap.2022.116250_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1539-6924.2008.01168.x","article-title":"Toxicity testing in the 21st century: implications for human health risk assessment","volume":"29","author":"Kavlock","year":"2009","journal-title":"Risk Anal."},{"key":"10.1016\/j.taap.2022.116250_bb0195","doi-asserted-by":"crossref","first-page":"119607","DOI":"10.1016\/j.lfs.2021.119607","article-title":"Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies","volume":"277","author":"Kim","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2022.116250_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12859-017-1638-4","article-title":"Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints","volume":"18","author":"Kim","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.taap.2022.116250_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.taap.2022.116250_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261854","article-title":"A gene expression biomarker for predictive toxicology to identify chemical modulators of NF-kappaB","volume":"17","author":"Korunes","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2022.116250_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/biology11020209","article-title":"High-throughput chemical screening and structure-based models to predict hERG inhibition","volume":"11","author":"Krishna","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.taap.2022.116250_bb0220","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2022.116250_bb0225","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12859-019-2814-5","article-title":"Computational determination of hERG-related cardiotoxicity of drug candidates","volume":"20","author":"Lee","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.taap.2022.116250_bb0230","doi-asserted-by":"crossref","first-page":"47008","DOI":"10.1289\/EHP6993","article-title":"Profiling the Tox21 chemical collection for acetylcholinesterase inhibition","volume":"129","author":"Li","year":"2021","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2022.116250_bb0235","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/CIRCULATIONAHA.113.001883","article-title":"Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity","volume":"127","author":"Liang","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.taap.2022.116250_bb0240","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/jf050918f","article-title":"QSAR models for Daphnia magna toxicity prediction of benzoxazinone allelochemicals and their transformation products","volume":"54","author":"Lo Piparo","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2022.116250_bb0245","doi-asserted-by":"crossref","first-page":"114368","DOI":"10.1016\/j.bcp.2020.114368","article-title":"Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library","volume":"184","author":"Lynch","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2022.116250_bb0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/acs.chemrestox.0c00322","article-title":"Deep graph learning with property augmentation for predicting drug-induced liver injury","volume":"34","author":"Ma","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0255","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14740338.2017.1351541","article-title":"Breast cancer treatment-induced cardiotoxicity","volume":"16","author":"Martel","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2022.116250_bb0005","author":"NCATS"},{"key":"10.1016\/j.taap.2022.116250_bb0260","author":"NCATS"},{"key":"10.1016\/j.taap.2022.116250_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.04.001","article-title":"Repurposing drugs as COVID-19 therapies: a toxicity evaluation","author":"Ngan","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.taap.2022.116250_bib442","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00204-022-03291-5","article-title":"Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation","volume":"96","author":"Ooka","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910206","article-title":"Insights into the genetic variations of human cytochrome P450 2C9: structural analysis, characterization and comparison","volume":"22","author":"Parikh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2022.116250_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha (ERalpha) and beta (ERbeta): subtype-selective ligands and clinical potential","volume":"90","author":"Paterni","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.taap.2022.116250_bb0280","author":"PubChem"},{"key":"10.1016\/j.taap.2022.116250_bb0285","author":"PubChem"},{"key":"10.1016\/j.taap.2022.116250_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2022.116250_bb0295","series-title":"StatPearls","author":"Reed","year":"2021"},{"key":"10.1016\/j.taap.2022.116250_bb0300","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/acs.chemrestox.0c00264","article-title":"The Tox21 10K compound library: collaborative chemistry advancing toxicology","volume":"34","author":"Richard","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0305","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.numecd.2020.01.014","article-title":"Artificial sweeteners impair endothelial vascular reactivity: preliminary results in rodents","volume":"30","author":"Risdon","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.taap.2022.116250_bb0310","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2022.116250_bb0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12032-017-1028-9","article-title":"Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis","volume":"34","author":"Roviello","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.taap.2022.116250_bb0320","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.semcdb.2010.09.011","article-title":"ErbB signaling in cardiac development and disease","volume":"21","author":"Sanchez-Soria","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2022.116250_bb0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ctrv.2017.07.006","article-title":"Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies","volume":"59","author":"Santoni","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"8","key":"10.1016\/j.taap.2022.116250_bib441","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1289\/ehp.1104709","article-title":"Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach","volume":"120","author":"Shukla","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2022.116250_bb0330","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1021\/acs.jcim.8b00150","article-title":"The catch-22 of predicting hERG blockade using publicly accessible bioactivity data","volume":"58","author":"Siramshetty","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2022.116250_bb0335","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/minf.201200065","article-title":"Prediction of cytochrome P450 profiles of environmental chemicals with QSAR models built from drug-like molecules","volume":"31","author":"Sun","year":"2012","journal-title":"Mol. Inform."},{"key":"10.1016\/j.taap.2022.116250_bb0340","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biopha.2018.02.067","article-title":"Abiraterone acetate in the treatment of prostate cancer","volume":"101","author":"Thakur","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2022.116250_bb0345","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1289\/ehp.1205784","article-title":"Improving the human hazard characterization of chemicals: a Tox21 update","volume":"121","author":"Tice","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2022.116250_bb0350","first-page":"869","article-title":"Chemotherapy-induced cardiotoxicity: detection, prevention, and management","volume":"30","author":"Truong","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.taap.2022.116250_bb0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrgastro.2011.22","article-title":"Mechanisms of drug-induced liver injury: from bedside to bench","volume":"8","author":"Tujios","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2022.116250_bb0010","author":"U.S. FDA"},{"key":"10.1016\/j.taap.2022.116250_bb0360","doi-asserted-by":"crossref","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","article-title":"Drug-induced mitochondrial dysfunction and cardiotoxicity","volume":"309","author":"Varga","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2022.116250_bb0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02986439","article-title":"A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C","volume":"5","author":"Verweij","year":"1988","journal-title":"Med. Oncol. Tumor Pharm."},{"key":"10.1016\/j.taap.2022.116250_bb0370","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02934854","article-title":"Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C","volume":"2","author":"Villani","year":"1985","journal-title":"Med. Oncol. Tumor Pharm."},{"key":"10.1016\/j.taap.2022.116250_bb0375","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: a review for clinicians","volume":"171","author":"Voican","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.taap.2022.116250_bb0380","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","article-title":"CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice","volume":"42","author":"Wagner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2022.116250_bb0385","doi-asserted-by":"crossref","first-page":"D400","DOI":"10.1093\/nar\/gkr1132","article-title":"PubChem\u2019s BioAssay database","volume":"40","author":"Wang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2022.116250_bb0390","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/17425255.2014.963555","article-title":"Pregnane X receptor and drug-induced liver injury","volume":"10","author":"Wang","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0395","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/070674378803300314","article-title":"Case report of hepatotoxicity associated with maprotiline","volume":"33","author":"Weinstein","year":"1988","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.taap.2022.116250_bb0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13321-017-0247-6","article-title":"The CompTox chemistry dashboard: a community data resource for environmental chemistry","volume":"9","author":"Williams","year":"2017","journal-title":"J. Cheminform."},{"key":"10.1016\/j.taap.2022.116250_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020352","article-title":"PPAR-mediated toxicology and applied pharmacology","volume":"9","author":"Xi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.taap.2022.116250_bb0415","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/acs.chemrestox.9b00305","article-title":"Predictive models for human organ toxicity based on in vitro bioactivity data and chemical structure","volume":"33","author":"Xu","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2022.116250_bb0420","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/ci500667v","article-title":"New publicly available chemical query language, CSRML, to support chemotype representations for application to data mining and modeling","volume":"55","author":"Yang","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2022.116250_bb0425","doi-asserted-by":"crossref","first-page":"T955","DOI":"10.1111\/1750-3841.12144","article-title":"Determination of xylazine and 2,6-xylidine in animal tissues by liquid chromatography-tandem mass spectrometry","volume":"78","author":"Zheng","year":"2013","journal-title":"J. Food Sci."},{"key":"10.1016\/j.taap.2022.116250_bb0430","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2022.116250_bb0435","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOL.0b013e328011c6fc","article-title":"Vitamin D and vascular calcification","volume":"18","author":"Zittermann","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.taap.2022.116250_bb0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal. Biochem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22003957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22003957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:03:08Z","timestamp":1758574988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X22003957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":89,"alternative-id":["S0041008X22003957"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.116250","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.116250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116250"}}